“Neola Medical is working hard towards the goal of obtaining market approval in the US with Neola, the company’s product for monitoring the lungs of premature babies. The company have now announced that the quality management system has been certified according to ISO 13485, a milestone on the road to CE marking and market approval by the FDA in the US.”

Don’t miss BioStock’s new article about Neola Medical and the company’s certification according to ISO 13485. In the article, the importance of the certification is highlighted and the milestone is explained in more detail. BioStock contacted CEO Hanna Sjöström to find out more.

Read the article here: BioStock – Neola Medical received ISO certification

Read more about the ISO certification in the press release: Press release